Rimonyx is actively seeking corporate partnerships to develop and commercialize several of its drug discovery programs. These include programs addressing inflammatory and autoimmune disorders. In addition, we are working on targets involved in cancer, viral disorders and amyloidosis.

 

Small Molecule Drug Discovery Partnerships

Rimonyx will enter into partnerships around any of the following:

• specific drug candidate;
• discovery-stage program in which Rimonyx and its partner jointly screen and together optimize any resulting drug leads; and
• broader collaboration addressing targets in a given therapeutic area

For more information about Rimonyx partnering opportunities, please contact:

Rimonyx Pharmaceuticals Ltd.
Kiryat Weizmann Science Park
Sapir St., 7
P.O. Box 4056
Ness-Ziona 70400
Israel
Tel.: 972-8-940-4593
Fax: 972-8-940-0917

E-mail: partnerships@rimonyx.com